Association of resistin gene 3′-untranslated region +62G→A polymorphism with type 2 diabetes and hypertension in a Chinese population

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 3, 2003, Pages 1258-1263

  Tan, Mian Shin ^a   Chang, Shu Ying ^b   Chang, Dao Ming ^c   Tsai, Jack C R ^c   Lee, Yau Jiunn ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

^c PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HYPERTENSION; INSULIN METABOLISM; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; POLYMERASE CHAIN REACTION; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; RESISTIN GENE; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

3' UNTRANSLATED REGIONS; ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HORMONES, ECTOPIC; HUMANS; HYPERTENSION; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RESISTIN;

EID: 0037340407     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021453     Document Type: Article

References (33)

1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA 2001 The hormone resistin links obesity to diabetes. Nature 409:307-312
2. Steppan CM, Lazar MA 2002 Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13:18-23
3. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S 2002 Resistin, central obesity, and type 2 diabetes. Lancet 359:46-47
4. Nagaev I, Smith U 2001 Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285:561-564
5. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM 2002 Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 10:1-5
6. Savage DB, Sewter CP, Llenkm ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S 2001 Resistin/Fizz3 expression in relation to obesity and peroxisime proliferator-activated receptor-γ action in humans. Diabetes 50:2199-2202
7. Reaven GM 1988 Role of insulin resistance in human disease. Diabetes 37:1595-1607
8. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK 1990 Cardiovascular risk factors in confirmed pre-diabetic individuals: does the clock for coronary artery disease start ticking before the onset of clinical diabetes? JAMA 263:2893-2898
9. Cao H, Hegele RA 2001 Single nucleotide polymorphisms of the resistin (RSTN) gene. J Hum Genet 46:553-555
10. Pesole G, Mignone F, Gissi C, Grillo G, Licciulli F, Liuni S 2001 Structural and functional features of eukaryotic mRNA untranslated regions. Gene 276:73-81
11. Alberti KG, Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 15:539-553
12. Lee YJ, Tsai JC 2002 ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients, Diabetes Care 25:1002-1008
13. Lee YJ, Tsai JC 2001 Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism 50:1346-1350
14. Jupe ER, Badgett AA, Neas BR, Craft MA, Mitchell DS, Resta R, Mulvihill JJ, Aston CE, Thompson LF 2001 Single nucleotide polymorphism in prohibitin 39 untranslated region and breast-cancer susceptibility. Lancet 357:1588-1589
15. Wong PM, Yuan Q, Chen H, Sultzer BM, Chung SW 2001 A single point mutation at the 3′-UTR of Ran mRNA leads to profound changes in lipopolysaccharide endotoxin-mediated responses. J Biol Chem 276:33129-33138
16. Osawa H, Onuma H, Murakami A, Ochi M, Nishimiya T, Kata K, Shimizu I, Fujii Y, Ohashi J, Makino H 2002 Systemic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes. Diabetes 51:863-866
17. Sentinelli F, Romeo S, Arca M, Filippi E, Leonetti F, Banchieri M, DiMario U, Baroni MG 2002 Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes 51:860-862
18. Ma X, Warram JH, Trischitta V, Doria A 2002 Genetic variations at the resistin locus and risk of type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87:4407-4410
19. Wang H, Chu WS, Hemphill C, Elbein SC 2002 Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87:2520-2524
20. Pizzuti A, Argiolas A, Di Paola R, Baratta R, Rauseo A, Bozzali M, Vigneri R, Dallapiccola B, Trischitta V, Frittitta L 2002 An ATG repeat in the 3′-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J Clin Endocrinol Metab 87:4403-4406
21. Laakso M, Edelman SV, Breechtel G, Baron AD 1992 Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 41:1076-1073
22. Heise T, Magnusson K, Heinemann L, Sawicki PT 1998 Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension 32:243-248
23. Tack CJ, Ong MK, Lutterman JA, Smits P 1998 Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia 41:569-576
24. Yoshioka S, Nishino H, Shiraki T, Ikeda K, Koike H, Okuno A, Wada M, Fujiwara T, Horikoshi H 1993 Antihypertensive effects of CS-045 treatment in obese Zucker rats. Metabolism 42:75-80
25. Buckanan TA, Meehan WP, Jeng YY, Tang D, Chan TM, Nadler J, Scott S, Rude RK, Hsueh WA 1995 Blood pressure lowering by Pioglitazone: evidence for a direct vascular effect. J Clin Invest 96:354-360
26. Walker AB, Chattington PD, Buckingham RE, Williams G 1999 The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes 48:1448-1453
27. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J1994 Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188-1193
28. Ogihara T, Rakugi H, Ikegami H, Mikami H, Masuo K1995 Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. Am J Hypertens 8:316-320
29. Lewis GF, Carpenter A, Adeli K, Giacca A 2002 Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23:201-229
30. Ravussin E, Smith SR 2002 Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann NY Acad Sci 967:363-378
31. Kim K-H, Lee K, Moon YS, Sul HS 2001 A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276:11252-11256
32. Montani J-P, Antic V, Yang Z, Dulloo A 2002 Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 26(Suppl 2):S28-S38
33. Ferrari P, Weidmann P 1990 Insulin, insulin sensitivity and hypertension. J Hypertens 8:491-500